Atlas Trials

The INDORSE Study: Inhibition of Dipeptidyl Peptidase IV: Outcomes on Renal Sodium Excretion

Clinical trial NCT02406443 · COMPLETED

Trial details

NCT number
NCT02406443
Sponsor
University Health Network, Toronto
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Type 2 Diabetes
Start date
2015-03-01
Primary completion
2016-06-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.